EICHOR

Recruiting studies: Ctcl Mycosis Fungoides

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Registry for People With T-cell Lymphoma
Phase N/A · 26 location(s) · Memorial Sloan Kettering Cancer Center · NCT05978141 A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT07055477 Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
Phase N/A · 6 location(s) · Kyowa Kirin Co., Ltd. · NCT07132567 JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Phase 2 · 2 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06716658 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090 Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT04930653 Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825 Photopheresis in Early-stage Mycosis Fungoides
Phase 2 · 1 location(s) · Columbia University · NCT05680558 A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
Phase 1 · 3 location(s) · Memorial Sloan Kettering Cancer Center · NCT05296304 Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 · 1 location(s) · University of California, Irvine · NCT06580002 Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
EARLY_Phase 1 · 1 location(s) · Northwestern University · NCT05838599 Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00177268 Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03398161 Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT05956041 A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Se
Phase N/A · 10 location(s) · City of Hope Medical Center · NCT07003100 Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Phase 1 · 10 location(s) · SciTech Development, Inc. · NCT04234048 Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
Phase N/A · 18 location(s) · Fondazione Italiana Linfomi - ETS · NCT06588868 Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05357794 Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Phase 2 · 2 location(s) · Yale University · NCT05996185 ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Phase N/A · 13 location(s) · Stanford University · NCT02848274 Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell
Phase 1/Phase 2 · 4 location(s) · City of Hope Medical Center · NCT03011814 SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Phase N/A · 8 location(s) · Leiden University Medical Center · NCT07021495 Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06207812 Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Phase N/A · 1 location(s) · Lund University Hospital · NCT04904146 Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT03587844 Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL
Phase N/A · 1 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT06382844 A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in
Phase 1 · 2 location(s) · Mayo Clinic · NCT03017820 Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
Phase 2 · 1 location(s) · Stanford University · NCT04256018 Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643 A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Phase 2 · 15 location(s) · Prescient Therapeutics, Ltd. · NCT06854653

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →